These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11894009)

  • 1. Epidermal growth factor receptor family in lung cancer and premalignancy.
    Franklin WA; Veve R; Hirsch FR; Helfrich BA; Bunn PA
    Semin Oncol; 2002 Feb; 29(1 Suppl 4):3-14. PubMed ID: 11894009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
    Hirsch FR; Scagliotti GV; Langer CJ; Varella-Garcia M; Franklin WA
    Lung Cancer; 2003 Aug; 41 Suppl 1():S29-42. PubMed ID: 12867060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer.
    Arteaga CL; Khuri F; Krystal G; Sebti S
    Semin Oncol; 2002 Feb; 29(1 Suppl 4):15-26. PubMed ID: 11894010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.
    Kanematsu T; Yano S; Uehara H; Bando Y; Sone S
    Oncol Res; 2003; 13(5):289-98. PubMed ID: 12688680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
    Rusch V; Klimstra D; Linkov I; Dmitrovsky E
    Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.
    Erman M; Grunenwald D; Penault-Llorca F; Grenier J; Besse B; Validire P; Morat L; Girard P; Le Chevalier T; Sabatier L; Soria JC
    Lung Cancer; 2005 Mar; 47(3):315-23. PubMed ID: 15713515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive biomarkers to tyrosine kinase inhibitors for the epidermal growth factor receptor in non-small-cell lung cancer.
    De Luca A; Normanno N
    Curr Drug Targets; 2010 Jul; 11(7):851-64. PubMed ID: 20388064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2/neu expression in malignant lung tumors.
    Hirsch FR; Franklin WA; Veve R; Varella-Garcia M; Bunn PA
    Semin Oncol; 2002 Feb; 29(1 Suppl 4):51-8. PubMed ID: 11894014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer.
    Bunn PA; Franklin W
    Semin Oncol; 2002 Oct; 29(5 Suppl 14):38-44. PubMed ID: 12422312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.
    Roengvoraphoj M; Tsongalis GJ; Dragnev KH; Rigas JR
    Cancer Treat Rev; 2013 Dec; 39(8):839-50. PubMed ID: 23768755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF receptor as a therapeutic target.
    Levitzki A
    Lung Cancer; 2003 Aug; 41 Suppl 1():S9-14. PubMed ID: 12867057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer.
    Raben D; Helfrich BA; Chan D; Johnson G; Bunn PA
    Semin Oncol; 2002 Feb; 29(1 Suppl 4):37-46. PubMed ID: 11894012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway.
    Rosell R; Taron M; Reguart N; Isla D; Moran T
    Clin Cancer Res; 2006 Dec; 12(24):7222-31. PubMed ID: 17189393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.
    Chung C
    J Oncol Pharm Pract; 2016 Jun; 22(3):461-76. PubMed ID: 25855240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
    Earp HS; Dawson TL; Li X; Yu H
    Breast Cancer Res Treat; 1995 Jul; 35(1):115-32. PubMed ID: 7612898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.
    Chang HC; Chen YM; Tseng CC; Huang KT; Wang CC; Chen YC; Lai CH; Fang WF; Kao HC; Lin MC
    Tumour Biol; 2017 Mar; 39(3):1010428317695939. PubMed ID: 28351317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
    Balko JM; Potti A; Saunders C; Stromberg A; Haura EB; Black EP
    BMC Genomics; 2006 Nov; 7():289. PubMed ID: 17096850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.